Wellington Management Group LLP Makes New Investment in CryoPort, Inc. $CYRX

Wellington Management Group LLP acquired a new stake in CryoPort, Inc. (NASDAQ:CYRX) in the 2nd quarter, HoldingsChannel.com reports. The fund acquired 534,930 shares of the company’s stock, valued at approximately $8,398,000.

Other large investors have also bought and sold shares of the company. UBS Group AG lifted its position in shares of CryoPort by 112.7% during the 3rd quarter. UBS Group AG now owns 1,331,521 shares of the company’s stock valued at $12,623,000 after acquiring an additional 705,649 shares during the last quarter. Millennium Management LLC grew its holdings in shares of CryoPort by 23.8% in the 4th quarter. Millennium Management LLC now owns 3,244,802 shares of the company’s stock worth $31,150,000 after acquiring an additional 623,896 shares during the last quarter. Jacobs Levy Equity Management Inc. raised its position in shares of CryoPort by 283.1% during the third quarter. Jacobs Levy Equity Management Inc. now owns 524,288 shares of the company’s stock worth $4,970,000 after purchasing an additional 387,440 shares during the period. Mak Capital One LLC raised its position in shares of CryoPort by 46.6% during the fourth quarter. Mak Capital One LLC now owns 1,199,225 shares of the company’s stock worth $11,513,000 after purchasing an additional 381,063 shares during the period. Finally, First Eagle Investment Management LLC purchased a new stake in shares of CryoPort during the fourth quarter valued at $2,996,000. Institutional investors own 92.90% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the stock. BTIG Research raised their target price on shares of CryoPort from $17.00 to $25.00 and gave the stock a “buy” rating in a report on Friday, July 24th. KeyCorp boosted their price target on shares of CryoPort from $15.00 to $17.00 and gave the company an “overweight” rating in a report on Wednesday, May 20th. Weiss Ratings downgraded shares of CryoPort from a “hold (c-)” rating to a “sell (d)” rating in a research report on Monday, August 17th. Roth Capital reiterated a “buy” rating and set a $21.00 price objective on shares of CryoPort in a research report on Friday, August 7th. Finally, Craig Hallum boosted their target price on shares of CryoPort from $15.00 to $20.00 and gave the company a “buy” rating in a research note on Wednesday, June 3rd. Seven investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $18.00.

CryoPort Stock Down 2.2%

CYRX stock opened at $15.47 on Wednesday. The firm has a 50 day moving average of $15.70 and a two-hundred day moving average of $12.93. CryoPort, Inc. has a 12 month low of $7.61 and a 12 month high of $17.20. The company has a market capitalization of $783.56 million, a price-to-earnings ratio of -17.19 and a beta of 1.89.

CryoPort (NASDAQ:CYRX) last announced its quarterly earnings results on Thursday, August 6th. The company reported ($0.20) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.19) by ($0.01). CryoPort had a negative return on equity of 7.20% and a negative net margin of 20.05%.The company had revenue of $48.97 million during the quarter, compared to analyst estimates of $48.18 million. On average, research analysts expect that CryoPort, Inc. will post -0.83 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, CEO Jerrell Shelton sold 28,800 shares of the business’s stock in a transaction that occurred on Tuesday, August 11th. The stock was sold at an average price of $14.91, for a total transaction of $429,408.00. Following the sale, the chief executive officer directly owned 1,201,814 shares in the company, valued at approximately $17,919,046.74. The trade was a 2.34% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Edward J. Zecchini sold 33,600 shares of the business’s stock in a transaction on Thursday, June 11th. The shares were sold at an average price of $14.47, for a total transaction of $486,192.00. Following the completion of the sale, the insider directly owned 109,719 shares in the company, valued at $1,587,633.93. This trade represents a 23.44% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders own 9.50% of the company’s stock.

CryoPort Company Profile

CryoPort, Inc (NASDAQ: CYRX) is a global provider of temperature-controlled logistics solutions for the life sciences industry. The company specializes in cryogenic shipping for critical biological materials, supporting the development, clinical testing and commercialization of cell and gene therapies, biologics, vaccines and reproductive medicine. By offering end-to-end supply chain management, CryoPort helps ensure the integrity and viability of temperature-sensitive products from point of origin to destination.

CryoPort’s product portfolio includes proprietary cryogenic dry shippers, advanced active and passive thermal packaging, and real-time data monitoring platforms.